-
221
Relapsing and progressive MS: the sex-specific perspective
Published 2020-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
222
Locked-in syndrome revisited
Published 2023-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
223
An update on magnetic resonance imaging markers in AD
Published 2020-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
224
Ventricular tachycardia during basilar-type migraine attack
Published 2013-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
225
Diagnosis and management of central hypersomnias
Published 2012-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
226
Corrigendum to Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
Published 2022-05-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
227
Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis
Published 2024-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
228
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response
Published 2023-12-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
229
Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG)
Published 2020-08-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
230
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study
Published 2014-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
231
Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
Published 2020-06-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
232
Natalizumab: increased vigilance is required in treating patients with multiple sclerosis
Published 2008-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
233
The use of rotigotine in the treatment of restless legs syndrome
Published 2010-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
234
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials
Published 2023-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
235
Review: Escalating immunotherapy of multiple sclerosis
Published 2008-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
236
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review
Published 2022-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
237
Patisiran exposure in early pregnancy: a case report
Published 2024-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
238
Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review
Published 2023-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
239
Review: Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future
Published 2009-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
240
Contactin-associated protein 2 autoantibodies can be associated with multifocal motor-like neuropathy: a case report
Published 2023-08-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article